MedPath

Physical Activity in Men Newly Diagnosed With Prostate Cancer: A Feasibility Study

Not Applicable
Completed
Conditions
Prostate Cancer
Interventions
Behavioral: exrecise intervention
Registration Number
NCT03331458
Lead Sponsor
Duke University
Brief Summary

Recent research has indicated that physical activities incorporating moderate-intensity exercise can be safely performed during treatment and substantially reduces treatment-related side effects, such as fatigue, sleep disturbances, cognitive impairment, and nausea. However, little is known about physical activity levels prior to treatment and whether providing an exercise intervention pre-treatment may improve functional capacity during treatment.

The purpose of this study is to

1. Measure physical activity levels and functional capacity in men newly diagnosed with prostate cancer prior to treatment and

2. Explore whether a 2-week physical activity intervention is feasible during the pre-treatment timeframe:

1. Examine intervention safety and tolerance by self-report

2. Examine changes in functional capacity by 6-minute walk test

3. Examine changes in symptom experience by self-report

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
13
Inclusion Criteria
  • Newly diagnosed with prostate cancer
  • will not start treatment for at least 2 weeks
  • able to read and understand English
  • capable of giving informed consent
  • at least 18 years old
Read More
Exclusion Criteria
  • patients who are incompetent for interview (documented diagnosis of active psychosis or dementia)
  • unable to provide informed consent as assessed by the interviewer
  • too sick to participate, as judged by a member of the research team or the exercise physiologist
  • have been treated for another cancer
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
subjects with prostate cancerexrecise intervention-
Primary Outcome Measures
NameTimeMethod
Change in distress scorebaseline, 2 weeks post intervention

distress score

Change in rate of perceived exertionbaseline, 2 weeks post intervention

physical exertion score

Change in self-efficacy scorebaseline, 2 weeks post intervention

self-efficacy score

Change in symptom inventory scorebaseline, 2 weeks post intervention

description of symptoms

Change in balance testbaseline, 2 weeks post intervention

Ability to balance

Change in time up to go testbaseline, 2 weeks post intervention

Time to get up from chair, walk 30 meters and return to sit in chair

Change in Godin Leisure Time Scorebaseline, 2 weeks post intervention

physical activity score

Change in metabolic equivalentbaseline, 2 weeks post intervention

metabolic activity score

Change in 6 minute walk testbaseline, 2 weeks post intervention

Distance walked in 6 minutes

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Duke Raleigh Cancer Center

🇺🇸

Raleigh, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath